BERLIN — Patients with restless legs syndrome (RLS) for whom conventional therapies are contraindicated may benefit from a treatment usually reserved for patients with advanced Parkinson's disease and ...
August 4, 2011 — A new study is the first long-term prospective trial of dopamine agonist therapy in restless legs syndrome (RLS). The study, funded by UCB BioSciences and Schwarz Pharma, ...
Restless Legs Syndrome (RLS), or Willis-Ekbom disease (WED) is one of the most common chronic sensorimotor neurological conditions encountered by clinicians. It occurs in 5% to 10% of the adult ...
The American Academy of Sleep Medicine (AASM) has updated its guidelines for the treatment of restless legs syndrome (RLS) for the first time in 12 years. In this video interview, guideline author ...
Credit: Getty Images The American Academy of Sleep Medicine published guidance regarding the treatment of restless leg syndrome and periodic limb movement disorder. The American Academy of Sleep ...
Restless legs syndrome: a new practice guideline Evidence shows strong support for prescribing pramipexole, rotigotine, cabergoline, or gabapentin enacarbil to treat adults with restless legs syndrome ...
Restless legs syndrome (RLS), also known as Willis-Ekbom Disease, is a neurological condition that affects about 7% of people. Typical symptoms include an irresistible urge to move your legs, ...
Restless legs syndrome (RLS) is a common condition marked by uncomfortable lower-limb sensations that can keep you up at night. Research suggests that nutrients, such as vitamins C, D, and E, may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results